Ductal carcinoma in situ (DCIS) is a nonobligate precursor of invasive cancer, and its
detection, diagnosis, and management are controversial. DCIS incidence grew with the …

Automated breast (AB) ultrasonography (US) scanners have recently been brought to
market for breast imaging. AB US devices use mechanically driven wide linear-array …

Objectives To report our preliminary experience with shear-wave elastography (SWE) for
non-mass lesions (NMLs) in the breast and suggest a potential ancillary role of SWE for BI …

Efforts have continually been made to de-escalate treatment for breast cancer, with the goal
of balancing oncologic outcomes with complications and patient quality of life. In the early …

Recent published guidelines suggest that adequate margins for DCIS should be≥ 2 mm
after breast conserving surgery followed by radiotherapy (RT). Many groups now use this …

Ductal carcinoma in situ (DCIS) is a nonobligate precursor to invasive cancer that classically
presents as asymptomatic calcifications on screening mammography. The increase in DCIS …

A nonmass finding at US has been described as a discrete identifiable area of altered
echotexture compared with that of the surrounding breast tissue that does not conform to a …

Objective To analyze the features of non-mass-like (NML) breast lesions on ultrasound (US)
and determine their corresponding malignancy rate and to stratify these lesion patterns …

Ductal carcinoma in situ (DCIS) of the breast is a group of heterogeneous epithelial
proliferations confined to the milk ducts that nearly always present in asymptomatic women …

Abstract The Japan Association of Breast and Thyroid Sonology (JABTS) proposed, in 2003,
a conceptual classification system for non-mass abnormalities to be applied in addition to …